CVS Health Corp.
Bear Case (25th pct.)
-52.9% vs price
Base Case (Median)
-50.7% vs price
Bull Case (75th pct.)
-32.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $30.72 | -71.3% | High (40%) |
| PE Comparable | $50.54 | -52.8% | Medium (25%) |
| Graham Number | $55.06 | -48.6% | Medium (40%) |
| EV/EBITDA | $77.83 | -27.3% | Medium (20%) |
| EV/FCF | $116.72 | 9.0% | Medium (20%) |
| Earnings Power Value | $50.41 | -52.9% | Medium (50%) |
Based on 6 out of 8 methods, CVS appears overvalued at the current price of $107.07. The base case fair value of $52.80 implies 50.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.